Steven Howard & Chris Abell 
Fragment-Based Drug Discovery [PDF ebook] 

Soporte

Fragment-based drug discovery is a rapidly evolving area of research, which has recently seen new applications in areas such as epigenetics, GPCRs and the identification of novel allosteric binding pockets. The first fragment-derived drug was recently approved for the treatment of melanoma. It is hoped that this approval is just the beginning of the many drugs yet to be discovered using this fascinating technique.

This book is written from a Chemist’s perspective and comprehensively assesses the impact of fragment-based drug discovery on a wide variety of areas of medicinal chemistry. It will prove to be an invaluable resource for medicinal chemists working in academia and industry, as well as anyone interested in novel drug discovery techniques.

€229.99
Métodos de pago

Tabla de materias

Different flavours of Fragments; Advances in SPR Technology; Applications of NMR in Fragment-Based Drug Discovery; Issues around Fragments as an Approach, including a Computational/in silico Perspectives on Fragment-Based Drug Discovery; Fragment-Based Drug Discovery of Kinase Inhibitors; Fragment-Based Discovery of Antibacterials; Strategies for Fragment-Based Lead Generation; Fragment-Based Approaches to Epigenetic Targets; Application of Fragment-Based Drug Discovery to GPCRs; Fragment-Based Drug Discovery applied to Protein-Protein Interactions; Probing Difficult Targets

¡Compre este libro electrónico y obtenga 1 más GRATIS!
Idioma Inglés ● Formato PDF ● Páginas 314 ● ISBN 9781782620938 ● Tamaño de archivo 30.3 MB ● Editor Steven Howard & Chris Abell ● Editorial Royal Society of Chemistry ● Ciudad Cambridge ● País GB ● Publicado 2015 ● Edición 1 ● Descargable 24 meses ● Divisa EUR ● ID 5762102 ● Protección de copia Adobe DRM
Requiere lector de ebook con capacidad DRM

Más ebooks del mismo autor / Editor

11.837 Ebooks en esta categoría